Covered, not compounding. The $0.96 annualized distribution is covered — 2025 modified FFO of $1.52 a share puts the payout at about 63%, net debt is only about 3.4× EBITDA, and the July 2026 refinancing leaves no significant maturities until 2029. But the payout has not grown since 2022, modified FFO per share fell from $1.61 in 2024 to $1.52 in 2025, and hotel income has no long leases behind it — the distribution was cut to $0.30 in 2020 when travel stopped. For a REIT, the House reads AFFO payout — never the EPS payout, which depreciation makes meaningless — and here coverage passes while growth does not. This is not trap treatment: no return-of-capital evidence was verified, and comparable-hotel RevPAR grew 5.3% in Q2 2026.
Key risk: Hotel income moves with travel, not with leases — a demand downturn hits occupancy and room rates within weeks, and there is no contracted rent to fall back on while the dividend stays flat.
Changes if: The modified FFO payout pushes toward 80% or higher, comparable-hotel RevPAR turns negative for consecutive quarters, or leverage rises well past ~3.4×. The cushion is the verdict.
- ✓AFFO coverage check: ~63% of 2025 modified FFO ($0.96 on $1.52 a share) leaves a real cushion, and 2026 guidance points to about $1.59 a share.
- ✓Debt check: Net debt of about 3.4× EBITDA at end of 2025, with the July 2026 refinancing pushing significant maturities out to 2029.
- !Growth check: Flagged — the distribution has been $0.96 a year since 2022, and modified FFO per share fell in 2025. Income here holds its level; it does not compound.
What this grade doesn't say: It screens the dividend only — covered, real, compounding. It says nothing about valuation or price: a well-covered payer can still be overpriced, and its price can still fall.